US Stock MarketDetailed Quotes
BWAY Brainsway
- 10.210
- +0.300+3.03%
Close Dec 3 16:00 ET
- 10.210
- 0.0000.00%
Post 16:00 ET
191.77MMarket Cap127.63P/E (TTM)
10.390High9.860Low246.26KVolume10.300Open9.910Pre Close2.52MTurnover1.93%Turnover RatioLossP/E (Static)18.78MShares10.98052wk High4.36P/B130.39MFloat Cap4.61052wk Low--Dividend TTM12.77MShs Float12.530Historical High--Div YieldTTM5.35%Amplitude1.380Historical Low10.227Avg Price1Lot Size
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Brainsway Stock Forum
BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy
BrainsWay (NASDAQ & TASE: BWAY) announced positive feasibility clinical data for their Deep TMS™ therapy in treating peripheral neuropathic pain. The double-blind, randomized crossover trial involved 17 patients who received either active Deep TMS or sham treatment for five days, followed by a nine-week washout period before switching treatments. Results demonstrated significant r...
BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada
BrainsWay has announced an exclusive multi-year distribution agreement to market its Deep Transcranial Magnetic Stimulation (Deep TMS) system in Canada. The agreement involves a specialty distributor serving acute and non-acute healthcare sectors, and includes minimum quantity orders, starting with 11 systems in 2024. BrainsWay’s CEO, Hadar Levy, emphasized the significance of exp...
BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression
BrainsWay has announced that the FDA has expanded the indication for its Deep Transcranial Magnetic Stimulation system (Deep TMS™) to treat major depressive disorder (MDD) in patients aged 22 to 86, extending beyond the previous age limit of 68. This marks the company's 10th FDA clearance, making their Deep TMS the only TMS device approved for depression treatment in patients over 68. The expanded lab...
Depression is a formidable adversary at any age, but it poses unique challenges for the elderly. Traditional treatments often fall short, leaving a gap that demands innovative solutions. Enter Deep Transcranial Magnetic Stimulation (Deep TMS) technology, a beacon of hope for those battling late-life depression. Recent findings f...
FIRST SIGNED OF MORE UPTREND: $9.37
NEED IT TO BREAK OVER: $9.54
key indicator for MORE uptrend $9.73
confirmation uptrend - $10.26
mini breakout - $10.69
full breakout - $10.91
SEMI PARABOLIC - $11.17
stop loss — $8.91
support - $8.66 $Brainsway (BWAY.US)$
FIRST SIGNED OF MORE UPTREND: $10.20
NEED IT TO BREAK OVER: $10.26
key indicator for MORE uptrend $10.69
confirmation uptrend - $10.91
mini breakout - $11.17
full breakout - $11.66
SEMI PARABOLIC - $12.65
stop loss — $9.54
support - $8.66 $Brainsway (BWAY.US)$
No comment yet